Source: Health Products Regulatory Authority (IE) Revision Year: 2020 Publisher: BASF AS, P.O Box 420, 1327 Lysaker, Norway
Omacor 1000 mg Soft Capsules.
| Pharmaceutical Form |
|---|
|
Capsule, soft Soft, oblong, transparent gelatin capsules containing pale yellow oil. |
One capsule contains: Omega-3-acid ethyl esters 90 1000 mg comprising 840 mg eicosapentaenoic acid (EPA) ethyl ester (460mg) and docosahexaenoic acid (DHA) ethyl ester (380mg), including also as antioxidant 4 mg d-alpha-tocopherol (mixed with a vegetable oil e.g. soya oil).
For a full list of excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Docosahexaenoic acid |
Docosahexaenoic acid (DHA) is an omega-3 fatty acid that is a primary structural component of the human brain, cerebral cortex, skin, and retina. It can be synthesized from alpha-linolenic acid or obtained directly from maternal milk (breast milk), fish oil, or algae oil. |
|
| Eicosapentaenoic acid |
Eicosapentaenoic acid (EPA; also icosapentaenoic acid) is an omega-3 fatty acid. It also has the trivial name timnodonic acid. Eicosapentaenoic acid is a polyunsaturated fatty acid (PUFA) that acts as a precursor for prostaglandin-3 (which inhibits platelet aggregation), thromboxane-3, and leukotriene-5 eicosanoids. Eicosapentaenoic acid is both a precursor and the hydrolytic breakdown product of eicosapentaenoyl ethanolamide (EPEA: C22H35NO2; 20:5,n-3). |
| List of Excipients |
|---|
|
Capsule shell: Gelatine |
White high density polyethylene (HDPE) bottle:
Not all pack sizes may be marketed.
BASF AS, P.O Box 420, 1327 Lysaker, Norway
PA1099/001/001
Date of first authorisation: 08 August 2003
Date of last renewal: 22 July 2006
| Drug | Countries | |
|---|---|---|
| OMACOR | Austria, Cyprus, Ecuador, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Singapore, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
